Sequential topoisomerase I (topo I) and topoisomerase II (topo II) inhibitors in relapsed/refractory aggressive NHL: Results of CALGB 59906, a phase II study of doxorubicin and topotecan.

被引：0
作者：
Smith, SM
Johnson, JL
Niedzwiecki, D
Eder, JP
Canellos, GP
Cheson, BD
Bartlett, NL
机构：
[1] Univ Chicago, Dept Med, Chicago, IL 60637 USA
[2] Duke Univ, Canc & Leukemia Grp B, Ctr Stat, Durham, NC USA
[3] Dana Farber Canc Inst, Boston, MA 02115 USA
[4] Georgetown Univ, Vincent T Lombardi Canc Res Ctr, Washington, DC 20007 USA
[5] Washington Univ, St Louis, MO USA
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
10.1182/blood.V104.11.2500.2500
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2500
引用
收藏
页码：685A / 686A
页数：2
相关论文
共 50 条
  • [41] Phase I/II trial of clofarabine in refractory and/or relapsed non-hodgkin's lymphoma (NHL)
    Nabhan, C.
    Fried, W.
    Galvez, A.
    Venugopal, P.
    Gozun, P.
    Bitran, J. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [42] Phase I/II study of bortezomib in combination with liposomal doxorubicin and melphalan in relapsed or refractory multiple myeloma.
    Chari, A
    Kaplan, L
    Linker, C
    Damon, LE
    Navarro, WH
    Martin, T
    BLOOD, 2005, 106 (11) : 379B - 379B
  • [43] Phase II Study of 131I-MIBG with Five Days of Topotecan for Patients with Relapsed or Refractory Neuroblastoma (NB): Results of the French Study MITOP
    Defachelles, A. S.
    Bogart, E.
    Courbon, F.
    Oudoux, A.
    Cougnenc, O.
    Gambart, M.
    Corradini, N.
    Giraudet, A. L.
    Schleiermacher, G.
    Valteau-Couannet, D.
    Le Deley, M. C.
    Gauthier, H.
    PEDIATRIC BLOOD & CANCER, 2019, 66 : S321 - S321
  • [44] Phase I trial of GL331, a novel topoisomerase-II (T-II) inhibitor for advanced refractory cancer
    Fossella, FV
    Newman, R
    Gorelick, K
    Wester, M
    Kunz, AY
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 937 - 937
  • [45] Phase-II Trial of Rebeccamycin Analog, a Dual Topoisomerase-I and -II Inhibitor, in Relapsed "Sensitive" Small Cell Lung Cancer
    Schwandt, Anita
    Mekhail, Tarek
    Halmos, Balazs
    O'Brien, Timothy
    Ma, Patrick C.
    Fu, Pingfu
    Ivy, Percy
    Dowlati, Afshin
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (04) : 751 - 754
  • [46] A phase II study using a topoisomerase I-based approach in patients with multiply relapsed germ-cell tumours
    Shamash, J.
    Powles, T.
    Mutsvangwa, K.
    Wilson, P.
    Ansell, W.
    Walsh, E.
    Berney, D.
    Stebbing, J.
    Oliver, T.
    ANNALS OF ONCOLOGY, 2007, 18 (05) : 925 - 930
  • [47] Modeling the Effect of Phase II Conjugations on Topoisomerase I Poisoning: Pilot Study with Luteolin and Quercetin
    Dellafiora, Luca
    Mena, Pedro
    Del Rio, Daniele
    Cozzini, Pietro
    JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2014, 62 (25) : 5881 - 5886
  • [48] Phase I study of sequentially administered topoisomerase I inhibitor (irinotecan) and topoisomerase II inhibitor (etoposide) for metastatic non-small-cell lung cancer
    Ando, M
    Eguchi, K
    Shinkai, T
    Tamura, T
    Ohe, Y
    Yamamoto, N
    Kurata, T
    Kasai, T
    Ohmatsu, H
    Kubota, K
    Sekine, I
    Hojo, N
    Matsumoto, T
    Kodama, T
    Kakinuma, R
    Nishiwaki, Y
    Saijo, N
    BRITISH JOURNAL OF CANCER, 1997, 76 (11) : 1494 - 1499
  • [49] Phase I and pharmacologic study with the novel topoisomerase I/II inhibitor intoplicine administered as a 24-hour infusion
    van Gijn, R
    Huinink, WWT
    Rodenhuis, S
    Vermorken, JB
    van Tellingen, O
    Rosing, H
    van Warmerdam, LJC
    Alakl, MK
    Beijnen, JH
    ANNALS OF ONCOLOGY, 1998, 9 : 66 - 66
  • [50] Phase I study of sequentially administered topoisomerase I inhibitor (irinotecan) and topoisomerase II inhibitor (etoposide) for metastatic non-small-cell lung cancer
    M Ando
    K Eguchi
    T Shinkai
    T Tamura
    Y Ohe
    N Yamamoto
    T Kurata
    T Kasai
    H Ohmatsu
    K Kubota
    I Sekine
    N Hojo
    T Matsumoto
    T Kodama
    R Kakinuma
    Y Nishiwaki
    N Saijo
    British Journal of Cancer, 1997, 76 : 1494 - 1499
12345